FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/12/2023
Back to search
Official data from USPTO
LIGHTBULB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIGHTBULB
ST13
US500000079333599Class
1, 5, 9
Filing
79333599
Registration
7051196
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
09/12/2023
Trademark type
Word
Nice classes
1, 5, 9
Filing date
09/22/2021
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CAPSHAW, DANIEL
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Touchlight IP Limited
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparationsenzymes and DNA for the preparation of nucleic acid for scientific researchnamely nucleic acid constructs; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in agri-biotechnology and nanotechnologynamely nucleic acid constructs other than for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for use in nanotechnology applications including data storagedata retrieval and computingnamely nucleic acid constructs other than for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in nanotechnology applications including data storagedata retrieval and computing other than for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in nanotechnology applications including data storagedata retrieval and computingnamely nucleic acid constructs other than for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds; nucleic acids and nucleic acid analogues for labellingimaging and sensing applications for scientific and research purposes; nucleic acids and nucleic acid analogues as smart materials for scientific and research purposes; two-dimensional and three-dimensional nucleic acids and nucleic acid analogues for creating nanostructures and scaffolds for scientific and research purposes; parts and fittings for all the aforesaid technology; all the aforesaid goods for use in nanotechnology applications including data storagedata retrieval and computing
Class 5
Vaccines; DNA based vaccines; DNA extractsnucleic acid sequences and chemical reagents for medical use; therapeutic DNAnucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds
Class 9
Electronic componentsnano-wiressemi-conductorstransistorsrectifiersdiodesbatteries all the aforesaid goods being manufactured from or including nucleic acidsnucleic acid constructs and nucleic acid analogues; structural parts and fittings for all the aforesaid goods
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/19/2023
FIMP
FINAL DISPOSITION PROCESSED
08/19/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/16/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2023
PUBO
PUBLISHED FOR OPPOSITION
02/28/2023
GPNX
NOTIFICATION PROCESSED BY IB
02/27/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/24/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/23/2022
RFNT
REFUSAL PROCESSED BY IB
07/20/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/28/2022
RFRR
REFUSAL PROCESSED BY MPU
06/28/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/11/2022
CNRT
NON-FINAL ACTION WRITTEN
06/10/2022
DOCK
ASSIGNED TO EXAMINER
06/07/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/17/2022
Continuous trademark protection
Get notified about every new filing that threatens LIGHTBULB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.